VolitionRX Ltd.

VolitionRX Ltd.
Stock Exchange NYSE
EPS
$0.53
Market Cap
$122.79 M
Shares Outstanding
39.48 M
Public Float
22.41 M

Profile

Address
1 Scotts Road
Singapore CE 228208
Singapore
Employees -
Website http://www.volitionrx.com
Updated 07/08/2019
VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore.

Financials

View All

Cameron John Reynolds
President, Chief Executive Officer & Director
Guy Archibald Innes
Lead Independent Non-Executive Director